MYRIAD GENETICS INC - 8-K Filing
On June 4, 2026, Myriad Genetics held its annual meeting where shareholders approved an amendment increasing the share reserve of the Amended and Restated 2012 Employee Stock Purchase Plan by 4 million shares. Shareholders also approved the new 2026 Equity Incentive Plan with a total initial share reserve of 8,463,567 shares. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security HoldersOn June 4, 2026, the Company held its Annual Meeting, 9.01 Financial Statements and Exhibits)
Tickers: $MYGN